ENDEFR
Home › Poland › ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA

ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA

spółka akcyjna (S.A.) · STAROGARD GDAŃSKI, Poland · LEI 2594009ZRAEVZV3U7A14
LEI activegroup parent

Summary

ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA is registered in Poland and entered in the “National Court Register (KRS)” under number 0000127044. Its legal form is spółka akcyjna (S.A.) – public limited company (Poland). ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 24 Jan 2014 and the record was last updated on 23 Dec 2025; the next renewal is due by 25 Jan 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formspółka akcyjna (S.A.)
public limited company (Poland)
RegisterNational Court Register (KRS) · Register website
Registration number0000127044
Registration authorityMinistry of Justice
JurisdictionPoland
Registered addressSTAROGARD GDAŃSKI PELPLIŃSKA 19, 83-200 STAROGARD GDAŃSKI, Poland
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)22 Aug 2002
LEI2594009ZRAEVZV3U7A14
LEI statusactive
LEI first issued24 Jan 2014
LEI record last updated23 Dec 2025
Next LEI renewal25 Jan 2027
Corroboration of the LEI recordfully corroborated

Group membership

ZAKŁADY FARMACEUTYCZNE "POLPHARMA" SPÓŁKA AKCYJNA this entity
"ELEKTROCIEPŁOWNIA STAROGARD" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Poland

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
  • Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.

Direct subsidiaries (1)